# OnCo record jeffrey-weber (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jeffrey-weber/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jeffrey-weber" ;
  schema:name "Jeffrey S. Weber"@en ;
  schema:description "Led CheckMate 238, which made adjuvant nivolumab standard after melanoma surgery, and co-led the mRNA vaccine trial KEYNOTE-942."@en ;
  schema:url <https://onco.cc/people/jeffrey-weber/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Weber%20JS%5BAuthor%5D%20melanoma%20adjuvant> ;
  onco:tag "melanoma", "adjuvant", "vaccine" ;
  schema:jobTitle "Deputy Director, NYU Langone Perlmutter Cancer Center; Professor of Medicine" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/neoantigen-mrna-vaccine/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/intismeran-autogene/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/nyu-perlmutter/> ;
  onco:trials <https://onco.cc/trials/interpath-001/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-942-lancet-2024/> ;
  schema:affiliation <https://onco.cc/institutions/nyu-perlmutter/> .